欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是 分享到:

中国临床药理学与治疗学 ›› 2023, Vol. 28 ›› Issue (11): 1209-1218.doi: 10.12092/j.issn.1009-2501.2023.11.002

• 基础研究 • 上一篇    下一篇

黄芩素经由miR-125b-5p/IRF4轴进而促进喉癌细胞死亡并抑制其侵袭的机制研究

王  剑,孙永东,周兴玮,刘  雷,陈  龙,童兴科,朱佳丽   

  1. 西南医科大学附属中医院,耳鼻咽喉头颈外科,泸州  646000,四川
  • 收稿日期:2023-01-12 修回日期:2023-05-30 出版日期:2023-11-26 发布日期:2023-11-10
  • 通讯作者: 朱佳丽,女,副主任医师,研究方向:耳鼻咽喉。 E-mail:18357230@qq.com
  • 作者简介:王剑,男,硕士,副主任医师,研究方向:耳鼻咽喉头颈肿瘤。 E-mail:wangdaye147258369@163.com
  • 基金资助:
    西南医科大学附属中医医院联合项目课题(2020XYLH-024)

Baicalein promotes laryngeal cancer cell death and inhibits invasion via miR-125b-5p/IRF4 axis

WANG Jian, SUN Yongdong, ZHOU Xingwei, LIU Lei, CHEN Long, TONG Xingke, ZHU Jiali   

  1. Department of Otolaryngology, Head and Neck Surgery, Affiliated Hospital of Traditional Chinese Medicine, Southwest Medical University, Luzhou 646000, Sichuan, China
  • Received:2023-01-12 Revised:2023-05-30 Online:2023-11-26 Published:2023-11-10

摘要:

目的:探讨黄芩素诱导人喉癌细胞凋亡的机制。方法:选取AMC-HN-8细胞为研究对象,以不同浓度黄芩素(0、10、30、100、300 μmol/L)作用于细胞,采用CCK-8法检测其半数抑制浓度(IC50);采用蛋白质印迹法(Western blot)检测Bax、cleaved-caspase-3、Cyto-c、IRF4蛋白表达;RT-qPCR检测miR-125b-5p和IRF4的表达;双荧光素酶报告基因验证Targetscan预测结果(miR-125b-5p与IRF4-3'UTR的结合);凋亡和坏死抑制剂探索黄芩素诱导喉癌细胞的死亡方式。再将AMC-HN-8分为:空白组、黄芩素(IC50)、miR-125b-5p inhibitor组、黄芩素+inhibitor NC组、黄芩素+miR-125b-5p inhibitor组,细胞侵袭和克隆形成实验分别检测细胞的侵袭和增殖能力;采用流式细胞术检测细胞凋亡。结果:黄芩素以剂量依赖性方式抑制AMC-HN-8细胞的增殖,其IC50值为47.31 μmol/L;与空白组相比,47.31 μmol/L的黄芩素诱导了细胞凋亡和抑制了细胞侵袭,同时上调了miR-125b-5p的表达,抑制了IRF4的mRNA和蛋白的水平。荧光素酶结果表明,相对于NC模拟物(mimic)组,miR-125b-5p mimic能够抑制IRF4-3'UTR启动子的活性。黄芩素以凋亡的方式诱导喉癌细胞死亡。另外,47.31 μmol/L的黄芩素与miR-125b-5p inhibitor联合影响AMC-HN-8细胞行为学的结果表明,与空白组比较,黄芩素组细胞克隆数减少,侵袭能力减弱,凋亡增加;miR-125b-5p inhibitor组细胞克隆数增加,侵袭能力加强,凋亡减少;黄芩素+inhibitor NC组则与黄芩素一致,inhibitor NC对细胞行为学没有显著影响;黄芩素+miR-125b-5p inhibitor组细胞克隆、侵袭、凋亡则介于黄芩素组与miR-125b-5p inhibitor组之间。结论:黄芩素能抑制AMC-HN-8细胞增殖,其机制可能与miR-125b-5p靶向抑制IRF4的表达,诱导促凋亡蛋白Bax、cleaved-caspase-3、Cyto-c,抑制凋亡抑制蛋白Bcl-2从而诱导细胞凋亡有关。

关键词: 喉癌细胞, 黄芩素, 细胞凋亡, miR-125b-5p, IRF4

Abstract:

AIM: To investigate the mechanism of baicalin-induced apoptosis in human laryngeal cancer cells. METHODS: AMC-HN-8 cells were selected for the study, and baicalin was applied to the cells at different concentrations (0, 10, 30, 100, and 300 μmol/L), and the half-inhibitory concentration (IC50) was measured by the CCK-8 method. Bax, cleaved-caspase-3, Cyto-c, IRF4 protein expression by protein blotting (Western blot); miR-125b-5p and IRF4 expression by RT-qPCR. Dual-luciferase reporter gene validation of Targetscan prediction (binding of miR-125b-5p to IRF4-3'UTR); apoptosis and necrosis inhibitors explore the way baicalein induces death in laryngeal cancer cells. AMC-HN-8 was then divided into blank group, baicalein (IC50), miR-125b-5p inhibitor group, baicalein+inhibitor NC group, baicalein+miR-125b-5p inhibitor group, and cell invasion and clone formation assays to detect cell invasion and proliferation ability, respectively. Apoptosis was detected by flow cytometry. RESULTS: Baicalein inhibited the proliferation of AMC-HN-8 cells in a dose-dependent manner with an IC50 value of 47.31 μmol/L. Compared with the blank group, 47.31 μmol/L baicalin induced apoptosis and inhibited cell invasion, while upregulating the expression of miR-125b-5p and suppressing the mRNA and protein levels of IRF4. The luciferase results showed that the miR-125b-5p mimic was able to inhibit the activity of the IRF4-3'UTR promoter relative to the NC mimic (mimic) group. Baicalein induces laryngeal cancer cell death in an apoptotic manner. In addition, the combination of 47.31 μmol/L baicalin and miR-125b-5p inhibitor affected the behavior of AMC-HN-8 cells, showing that compared with the blank group, the baicalin group showed a decrease in the number of cell clones, weakened invasion ability, and increased apoptosis; the miR-125b-5p inhibitor group showed an increase in the number of cell clones, enhanced invasion ability and decreased apoptosis. The baicalin+inhibitor NC group was consistent with baicalin, with no significant effect of inhibitor NC on cell behavior. The cloning, invasion, and apoptosis of cells in the baicalin+miR-125b-5p inhibitor group were intermediate between the baicalin and miR-125b-5p inhibitor groups. CONCLUSION: Baicalin inhibits the proliferation of AMC-HN-8 cells, and the mechanism may be related to miR-125b-5p targeting to inhibit the expression of IRF4, inducing the pro-apoptotic proteins Bax, cleaved-caspase3, and Cyto-c, and inhibiting the apoptosis suppressor protein Bcl-2 thereby inducing apoptosis.

Key words: laryngeal cancer cells, baicalein, apoptosis, miR-125b-5p, IRF4

中图分类号: